arsenic has been researched along with leupeptins in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bunnett, NW; Garland, AM; Grady, EF; Payan, DG; Vigna, SR | 1 |
| Claeson, G; DeSoyza, T; Metternich, R; Niua, LH; Philipp, M | 1 |
| Chaudhary, PM; Matta, H; Sun, Q | 1 |
| Aono, J; Ishii, T; Itoh, K; Kumagai, Y; Li, B; Yamamoto, M; Yanagawa, T; Yoshida, H | 1 |
| Jing, Y; Lu, M; Waxman, S; Xia, L | 1 |
| Chen, SC; Chou, Y; Tian, TY; Tsai, CH; Ueng, KC; Yeh, HI | 1 |
| Berthoux, L; Bérubé, J; Nepveu-Traversy, ME | 1 |
| Berthoux, L; Létourneau-Hogan, A; Malbec, M; Nepveu-Traversy, ME; Pham, QT; Plourde, MB | 1 |
| Battastini, AM; Braganhol, E; Dalmolin, RJ; de Souza, LH; Gelain, DP; Moreira, JC; Pasquali, MA; Schröder, R; Zanotto-Filho, A | 1 |
| Chen, YC; Lee, WR; Shen, SC; Tsai, HH; Yang, LL; Yang, LY | 1 |
| Chen, X; Jung, YS; Yan, W; Zhang, J; Zhang, Y | 1 |
| Alvarez, EM; Blanco, GA; Cavaliere, V; Costantino, SN; Kornblihtt, L; Lombardo, T | 1 |
| Ho, JC; Lam, SK; Leung, LL; Li, YY; Zheng, CY | 1 |
13 other study(ies) available for arsenic and leupeptins
| Article | Year |
|---|---|
Agonist-induced internalization of the substance P (NK1) receptor expressed in epithelial cells.
Topics: Amino Acid Sequence; Ammonium Chloride; Animals; Arsenicals; Cell Line, Transformed; Chloroquine; Colchicine; Endocytosis; Epithelium; Hypertonic Solutions; Immune Sera; Immunohistochemistry; Kinetics; Leupeptins; Microscopy, Fluorescence; Molecular Sequence Data; Monensin; Peptides; Rats; Receptors, Neurokinin-1; Recombinant Proteins; Substance P; Time Factors; Transfection | 1994 |
pH-dependent binding constants for the inhibition of thrombin by transition state analogs.
Topics: Amino Acid Sequence; Animals; Antithrombins; Arsenicals; Boronic Acids; Carboxylic Acids; Cattle; Dipeptides; Hydrogen-Ion Concentration; Kinetics; Leupeptins; Molecular Sequence Data; Peptides; Piperidines; Thrombin | 1993 |
The human herpes virus 8-encoded viral FLICE inhibitory protein protects against growth factor withdrawal-induced apoptosis via NF-kappa B activation.
Topics: Acetylcysteine; Acute Disease; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-X Protein; Cell Transformation, Viral; Enzyme Activation; Gene Expression Regulation, Viral; Granulocyte-Macrophage Colony-Stimulating Factor; Herpesvirus 8, Human; Humans; I-kappa B Proteins; Leukemia, Myeloid; Leupeptins; Mitochondria; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; NF-kappa B; Oxides; Proto-Oncogene Proteins c-bcl-2; Recombinant Fusion Proteins; Recombinant Proteins; Rhadinovirus; Transcription, Genetic; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Viral Proteins | 2003 |
Activation of Nrf2 and accumulation of ubiquitinated A170 by arsenic in osteoblasts.
Topics: Adaptor Proteins, Signal Transducing; Animals; Arsenates; Arsenicals; Arsenites; Cell Line; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; DNA-Binding Proteins; Heat-Shock Proteins; Leupeptins; Macromolecular Substances; Mice; Multienzyme Complexes; NF-E2-Related Factor 2; Osteoblasts; Proteasome Endopeptidase Complex; Sequestosome-1 Protein; Trans-Activators; Transcriptional Activation; Ubiquitins | 2003 |
The cleavage product deltaPML-RARalpha contributes to all-trans retinoic acid-mediated differentiation in acute promyelocytic leukemia cells.
Topics: Acetamides; Antineoplastic Agents; Arsenic; Blotting, Western; Cell Differentiation; Cell Line; Cycloheximide; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Leukemia, Promyelocytic, Acute; Leupeptins; Luciferases; Multienzyme Complexes; Neoplasm Proteins; Oncogene Proteins, Fusion; Plasmids; Proteasome Endopeptidase Complex; Protein Synthesis Inhibitors; Transcriptional Activation; Transfection; Tretinoin; Tumor Cells, Cultured | 2003 |
Endothelial gap junctions are down-regulated by arsenic trioxide.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blotting, Western; Cell Line; Connexin 43; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Down-Regulation; Endothelium, Vascular; Gap Junctions; Humans; Immunohistochemistry; Leupeptins; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Oxides; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; von Willebrand Factor | 2007 |
TRIM5alpha and TRIMCyp form apparent hexamers and their multimeric state is not affected by exposure to restriction-sensitive viruses or by treatment with pharmacological inhibitors.
Topics: Animals; Aotidae; Arsenic Trioxide; Arsenicals; Cell Line; Cyclosporine; Enzyme Inhibitors; Leupeptins; Macaca mulatta; Mice; Oxides; Protein Multimerization; Proteins; Ubiquitin-Protein Ligases | 2009 |
Murine double minute 2 as a modulator of retroviral restrictions mediated by TRIM5alpha.
Topics: Animals; Antiviral Restriction Factors; Arsenic Trioxide; Arsenicals; Carrier Proteins; Cell Line; HIV-1; Humans; Infectious Anemia Virus, Equine; Leukemia Virus, Murine; Leupeptins; Mice; Oxides; Proteasome Endopeptidase Complex; Proto-Oncogene Proteins c-mdm2; RNA Interference; Tripartite Motif Proteins; Ubiquitin-Protein Ligases | 2010 |
NFκB inhibitors induce cell death in glioblastomas.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Astrocytes; Brain Neoplasms; Cell Cycle; Cell Death; Cell Line, Tumor; Cisplatin; Curcumin; Doxorubicin; Drug Synergism; Glioblastoma; Humans; Leupeptins; Molecular Targeted Therapy; NF-kappa B; Nitriles; Oxides; Rats; Sesquiterpenes; Signal Transduction; Sulfones | 2011 |
Quercetin enhancement of arsenic-induced apoptosis via stimulating ROS-dependent p53 protein ubiquitination in human HaCaT keratinocytes.
Topics: Animals; Apoptosis; Arsenic; Buthionine Sulfoximine; Cell Line; Cell Survival; Fibroblasts; Humans; Keratinocytes; Leupeptins; Membrane Potential, Mitochondrial; Mice; Models, Animal; NIH 3T3 Cells; Peroxides; Quercetin; Reactive Oxygen Species; Tumor Suppressor Protein p53; Ubiquitination | 2012 |
Arsenic suppresses cell survival via Pirh2-mediated proteasomal degradation of ΔNp63 protein.
Topics: Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Leupeptins; Oxides; Proteasome Endopeptidase Complex; Protein Stability; Proteolysis; RNA, Messenger; Signal Transduction; Time Factors; Transcription Factors; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases | 2013 |
Synergism of arsenic trioxide and MG132 in Raji cells attained by targeting BNIP3, autophagy, and mitochondria with low doses of valproic acid and vincristine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Autophagy; Cell Line, Tumor; Cell Survival; Drug Synergism; Enzyme Inhibitors; Humans; Leupeptins; Membrane Potential, Mitochondrial; Membrane Potentials; Membrane Proteins; Mitochondria; Oxides; Proto-Oncogene Proteins; U937 Cells; Up-Regulation; Valproic Acid; Vincristine | 2014 |
Combination effects of arsenic trioxide and fibroblast growth factor receptor inhibitor in squamous cell lung carcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Cysteine Proteinase Inhibitors; Drug Therapy, Combination; Female; Leupeptins; Lung Neoplasms; Mice; Mice, Nude; Oxides; Pyrimidines; Receptor, Fibroblast Growth Factor, Type 1; Xenograft Model Antitumor Assays | 2016 |